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Abstract  
Introduction: Factor I deficiency or fibrinogen deficiency, is a rare inherited bleeding disorder related to fibrinogen 
function in the blood coagulation cascade. They are classified into afibrinogenemia, hypofibrinogenemia and 
dysfibrinogenemia. Afibrinogenemia is defined as a lack of fibrinogen in the blood, i.e. <20 mg/dl of plasma with a 
frequency between 0.5 and 2 per million. Hypofibrinogenemia is partial deficiency of fibrinogen with levels of 
20–80 mg/dl of plasma. Estimated frequency varies from 0.5 to 3 per million.  
Case Report: We report regarding a 46 year old female patient, who presented with complaints of severe headache and 
right sided weakness. Examination revealed right Hemiplegia with BP of 144/90 mm Hg. Investigations revealed 
Creatine Kinase: 470IU/L, normal Blood counts, ESR and CRP. Thyroid profile was normal. Fibrinogen levels were 
17.9mg/dl and repeat test after 1 week showed 24.6mg/dl. ECG showed incomplete left bundle branch block. 
Echocardiography was normal.  
Conclusion: Hypofibrinogenemia rarely manifests as intracranial hemorrhage but, commonly presents with oral, mucosal 
and gastro intestinal tract bleeding. Patients admitted with stroke should be evaluated for fibrinogen deficiency and more 
emphasis to be laid in case of intracranial hemorrhage and previous history of bleeding. 
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Introduction 
Factor I deficiency is a rare inherited bleeding disorder related to fibrinogen function in the coagulation 
cascade [1]. It is classified into three distinct disorders: afibrinogenemia, hypofibrinogenemia and 
dysfibrinogenemia [2]. Afibrinogenemia is defined as a lack of fibrinogen in the blood with 
<20 mg/deciliter of plasma with estimated frequency between 0.5 and 2 per million 
[2].Hypofibrinogenemia is defined as a partial deficiency of fibrinogen, clinically 20–80 mg/deciliter of 
plasma. Estimated frequency varies from <0.5 to 3 per million [2,3]. 
Among all the reported cases of fibrinogen disorders in registry, afibrinogenemia accounted for 24% of 
cases, hypofibrinogenemia accounted for 38%, and dysfibrinogenemia accounted for 38% [4]. These 
disorders follow autosomal dominant or autosomal recessive inheritance affecting both males and females. 
Dysfibrinogenemia and thrombosis may be overrepresented in women due to risk of thrombosis 
associated with pregnancy and the postpartum period.   
Case report 
A 46 year-old woman was bought to Emergency room with sudden loss of consciousness, left sided 
weakness of body and history of headache. As GCS was 5/15 patient was intubated and mechanically 
ventilated in Intensive care unit. History from husband revealed headache, epistaxis, cough with 
expectoration and shortness of breath from 4 days for which she was admitted in local clinic. No history 
of diabetes, hypertension or ischemic heart disease was obtained.  
 
As the condition of the patient deteriorated, she was referred from that clinic.  Relatives denied illegal 
drug use. Her physical examination showed BP of 140/90mm hg, cyanosis, increased respiratory (30/min) 
and heart (120/min) rates. Babinski’s reflex was elicited on right side. Chest Radiography showed 
alveolointerstitial infiltrate in right basal area. Computerized tomography of Brain revealed intracranial 
hemorrhage in the left cerebral hemisphere extending into ventricles (Figures 1, 2, 3 and 4). 
Investigations revealed total white blood cell count of 12,100 /mm3 (Neutrophils 24%, Lymphocytes 70%, 
Eosinophils 3%, monocytes 3%) ESR 52mm/hr), Hemoglobin of 10mg/dl and platelet count was 179,000. 
The arterial blood gases had pH of 7.38, a PO2 of 65 mmHg, PCO2 of 35.5mmHg and 17.9 mmol/l of 
bicarbonate. Renal function test was normal with Creatinine of 1.4mg/dl and Blood urea of 30mg/dl. 
Liver function test was normal. Echocardiography was normal. 
 
Patient did not have history of Comorbid conditions and history of recurrent mucosal bleeding in form of 
epistaxis and menorrhagia was present. Patient had history of 3 times abortion in 4th, 6th and 8th months of 
pregnancy. Investigations showed fibrinogen level of 17.9mg/dl, Factor VIII 120.2%, PT > 2 minutes, 
APTT > 3 minutes, TT 33.8 sec. History from relatives revealed that her father had similar bleeding 
episodes and death due to intracranial hemorrhage.  
 
Patient was given fibrinogen concentrate to maintain level more than 0.8g/l. Fibrinogen concentrate is 
available as a powder to be dissolved in 50 ml of water and be given as a slow IV injection. The 
advantages of fibrinogen concentrate over cryoprecipitate are that it has less viral transmission, less 
immunogenic, lesser thromboembolism events [5]. Condition of patient improved over a period of 3 days 
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with no requirement of mechanical ventilation. Patient was shifted to medical ward after a period of 7 
days. Patient was advised physiotherapy and monitoring of fibrinogen levels. 
 
 
 
 
Figure 1 Intracranial hemorrhage in 
the left cerebral hemisphere 
extending into ventricles
Figure 2 CT Brain showing 
Intracranial hemorrhage extending 
from right to left ventricles
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Figure 4 CT Brain showing 
intracranial hemorrhage in 
parenchyma and meningeal spaces
Figure 3 Intracranial 
hemorrhage causing midline 
shift
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Discussion 
Fibrinogen is a 340-kD glycoprotein that is synthesized in the liver and circulates in plasma at a 
concentration of 2-4 g/L, with a half-life of 4 days [6]. A hexamer, consisting of 3 paired polypeptide 
chains: A-α, B-β, and γ; A and B refer to specific polypeptides on 2 of the chains. Synthesis of the protein 
in hepatocytes is under the control of 3 genes FGA, FGB, FGG located within 50 kilobases (kb) on 
chromosome 4. It maintains haemostatic balance as a substrate for clot formation, binds to platelet to 
support aggregation, has role in wound healing and Fibrin clot is a template for both thrombin binding 
and fibrinolytic system [7]. Dose (g) = desired increment in g/L x plasma volume (plasma volume is 0.07 
x (1-hematocrit) x weight (kg). patient's personal and family history of bleeding and thrombosis should be 
taken into consideration for appropriate dosing of replacement therapy.  
 
In patients with hypofibrinogenemia, bleeding episodes are usually mild and may occur following trauma 
or surgery [8, 9].Our patient presenting with intracranial hemorrhage is rarely reported. Cryoprecipitate 
has been used as a source of fibrinogen; each bag contains 100-250 mg of fibrinogen. The guidelines for 
dysfibrinogenemia are not standardized due to a lack of sufficient data. 
Conclusion  
Hypofibrinogenemia is a rare disease occurring almost 1 in 1 million. Fibrinogen replacement therapy is 
effective in preventing hemorrhage along with continuous monitoring of fibrinogen levels. Patients 
admitted with stroke should be evaluated for fibrinogen deficiency and more emphasis to be laid in case 
of intracranial hemorrhage and previous history of bleeding. 
Consent 
Written informed consent was obtained from the patient for publication of this case report and 
accompanying images. 
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